Clinical Trials Browser

Phase 2 × Infiltrating Bladder Urothelial Carcinoma × Clear all

NCT03609216 2026-03-04

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Phase 2 Recruiting

Infiltrating Bladder Urothelial Carcinoma

NCT03419130 2018-12-07

Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer

Phase 2 Withdrawn

Infiltrating Bladder Urothelial Carcinoma